Close

FBR Remains Positive on Galectin Therapeutics' (GALT) Prospects in NASH-CX; Affirms at 'Market Perform'

Go back to FBR Remains Positive on Galectin Therapeutics' (GALT) Prospects in NASH-CX; Affirms at 'Market Perform'
GALECTIN (NASDAQ: GALT) Delayed: 3.29 --0 (-0%)
Previous Close $3.29    52 Week High $3.05 
Open $3.29    52 Week Low $0.49 
Day High $3.29    P/E N/A 
Day Low $3.29    EPS $-1.32 
Volume 300